Alpha 1 Adrenergic Receptor – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
The Alpha 1 Adrenergic Receptor pipeline drugs market research report outlays comprehensive information on the Alpha 1 Adrenergic Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Genito Urinary System, Ophthalmology, and Immunology which include indications of Schizophrenia, Post-Traumatic Stress Disorder (PTSD), Benign Prostatic Hyperplasia, Acute Renal Failure (ARF) (Acute Kidney Injury), Presbyopia, Ptosis, and Anaphylaxis. It also reviews key players involved in Alpha 1 Adrenergic Receptor targeted therapeutics development with respective active and dormant or discontinued projects.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Alpha 1 Adrenergic Receptor | Therapy Area |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Companies |
|
||
| Key Molecule Type |
|
||
Scope
- The report provides a snapshot of the global therapeutic landscape for Alpha 1 Adrenergic Receptor
- The report reviews Alpha 1 Adrenergic Receptor targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Alpha 1 Adrenergic Receptor targeted therapeutics and enlists all their major and minor projects
- The report assesses Alpha 1 Adrenergic Receptor targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Alpha 1 Adrenergic Receptor targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Alpha 1 Adrenergic Receptor Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Alpha 1 Adrenergic Receptor development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Key Players
3Z ehf9 Meters Biopharma Inc
Advanced Innovative Partners Inc
Ahn-Gook Pharmaceutical Co Ltd
Angelini Pharma SpA
Aquestive Therapeutics Inc
Ascendia Pharmaceuticals Inc
AVVA Rus
Bioprojet SCR
Crossject SA
CuraSen Therapeutics Inc
Daewon Pharmaceutical Co Ltd
DongKoo Bio & Pharma Co Ltd
Eisai Co Ltd
Eurofarma Laboratorios SA
Geropharm
Glenmark Pharmaceuticals Ltd
Hanmi Pharmaceuticals Co Ltd
Innopharmax Inc
Jiangsu Kanion Pharmaceutical Co Ltd
Kinnov Therapeutics
Klaria Pharma Holding AB
Minerva Neurosciences Inc
Nasus Pharma Ltd
NLS Pharmaceutics AG
NVP Healthcare Co Ltd
Ocuphire Pharma Inc
Otsuka Pharmaceutical Co Ltd
Pharmazz Inc
Santen Pharmaceutical Co Ltd
SOM Biotech SL
Tonix Pharmaceuticals Holding Corp
Viatris Inc
Vivasc Therapeutics Inc
Wisdom Pharmaceutical Co Ltd
Zydus Lifesciences Ltd
Zyvran Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Pharmaceuticals reports